P. Hand

发表

Expression of ras oncogene p21 in prostate cancer.

M. Viola, F. Fromowitz, S. Oravez, 1986, The New England journal of medicine.

Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant

T. Yokota, P. Hand, J. Schlom, 2005, Cancer Immunology, Immunotherapy.

A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

P. Hand, J. Schlom, M. Nuti, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.

P. Hand, A. Thor, J. Schlom, 1985, Cancer research.

Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting.

S. Larson, P. Hand, J. Schlom, 1990, Cancer research.

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor.

P. Hand, J. Schlom, J. Mcarthur, 1999, Human gene therapy.

Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.

E. Padlan, P. Hand, J. Schlom, 1995, Hybridoma.

A CDR-grafted (humanized) domain-deleted antitumor antibody.

P. Hand, J. Schlom, D. Milenic, 1997, Cancer biotherapy & radiopharmaceuticals.

Generation and characterization of a single gene-encoded single-chain-tetravalent antitumor antibody.

E. Padlan, P. Hand, J. Schlom, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.

P. Hand, J. Schlom, M. Nuti, 1983, Cancer research.

ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.

P. Hand, A. Thor, D. Page, 1986, Laboratory investigation; a journal of technical methods and pathology.

Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.

G. Merlo, R. Mariani-Costantini, P. Hand, 1987, Cancer research.

Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

P. Hand, J. Schlom, D. Kufe, 1983, Cancer research.

Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts.

P. Hand, J. Schlom, A. Molinolo, 1989, International journal of radiation oncology, biology, physics.

A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populations

R. Mariani-Costantini, P. Hand, J. Schlom, 1982, International journal of cancer.

Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.

S. Pestka, P. Fisher, P. Hand, 1984, Cancer research.

Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody.

L. Liotta, C. N. Rao, P. Hand, 1985, Cancer research.

Use of Monoclonal Antibodies to Define the Diversity of Mammary Tumor Viral Gene Products in Virions and Mammary Tumors of the Genus Mus 1

P. Hand, J. Schlom, D. Colcher, 2006 .

Potential for recombinant immunoglobulin constructs in the management of carcinoma

P. Hand, J. Schlom, S. Kashmiri, 1994, Cancer.

Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibody.

P. Hand, J. Schlom, B. Calvo, 1993, Cancer Biotherapy.

Biologic properties of a Ch2 domain‐deleted recombinant immunoglobulin

P. Hand, J. Schlom, B. Calvo, 1993 .

TAG-72 as a Tumor Marker

M. Kuroki, P. Hand, A. Thor, 1992 .

Monoclonal antibodies and immobilized antibodies

C. A. White, R. Krauss, M. Melamed, 1987 .

Modulation of human tumor antigen expression.

S. Pestka, P. Hand, A. Thor, 1987, The Journal of laboratory and clinical medicine.

Monoclonal antibodies reactive with breast tumor-associated antigens.

S. Pestka, P. Fisher, P. Hand, 1985, Advances in cancer research.

Enhanced Expression of e-1la-ras p21 in Human Stomach Adenocarcinomas Defined by Immunoassays Using Monoclonal Antibodies and in Situ Hybridization

Jeffrey, G. Merlo, R. Mariani-Costantini, 2006 .

Generation and Characterization of a Recombinant/Chimeric B72.3 (Human 7^

P. Hand, R. Callahan, M. Bodmer, 2006 .

Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapy.

P. Hand, J. Schlom, D. Kufe, 1983, Laboratory and research methods in biology and medicine.

Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).

P. Hand, J. Schlom, D. Milenic, 1993, Biotechnology therapeutics.

Generation and Characterization of a Recombinant/Chimeric B72.3 (Human γ1)

P. Hand, J. Schlom, R. Callahan, 1991 .

Generation and characterization of a single-gene encoded single-chain immunoglobulin-interleukin-2 fusion protein.

Chen-feng Qi, P. Hand, J. Schlom, 1995, Immunotechnology : an international journal of immunological engineering.

Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.

S. Pestka, P. Hand, J. Schlom, 1988, Journal of interferon research.

Biology and Immunology of Human Carcinoma Cell Populations

S. Pestka, P. Fisher, R. Mariani-Costantini, 1984 .

Human Breast Cancer Markers Defined by Monoclonal Antibodies

S. Pestka, P. Hand, J. Schlom, 1985 .

Monoclonal antibodies to breast cancer‐associated antigens as potential reagents in the management of breast cancer

S. Pestka, P. Fisher, P. Hand, 1984, Cancer.

Antigenic Heterogeneity of Human Mammary Carcinoma Cells Defined by Monoclonal Antibodies

P. Hand, J. Schlom, M. Nuti, 1984 .

Potential Clinical Application of a Monoclonal Antibody to a Tumor Associated Glycoprotein (TAG-72)

P. Hand, A. Thor, J. Schlom, 1985 .

Development of quantitative liquid competition radioimmunoassays for the ras oncogene and proto‐oncogene p21 products

P. Hand, J. Schlom, A. Caruso, 1986, International Journal of Cancer.

Characterization and tumorigenicity of a butyrate-adapted T24 bladder cancer cell line.

P. Hand, A. Rabson, U. Flatow, 1989, Cancer investigation.

Generation and characterization of a novel single-gene-encoded single-chain immunoglobulin molecule with antigen binding activity and effector functions.

E. Padlan, P. Hand, J. Schlom, 1999, Molecular immunology.

Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line.

P. Hand, J. Schlom, M. Salgaller, 1991, Cancer research.

Genetically Engineered Antitumor Monoclonal Antibodies

P. Hand, S. Kashmiri, 1995 .

Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

P. Hand, A. Thor, J. Schlom, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases

P. Hand, A. Thor, J. Schlom, 1984, Nature.

The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.

P. Hand, J. Schlom, J. Kantor, 1995, Cancer research.

Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies

P. Hand, J. Schlom, M. Salgaller, 2005, Cancer Immunology, Immunotherapy.

Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors.

P. Hand, G. Sal, F. Biasi, 1989 .

Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.

P. Hand, A. Thor, J. Schlom, 1986, Cancer research.

DIVERSITY OF MOUSE MAMMARY TUMOR VIRUS GENETIC INFORMATION AND GENE PRODUCTS IN RODENTS

P. Hand, J. Schlom, R. Callahan, 1978 .

Monoclonal Antibodies Generated to a Synthetic Peptide Define Ras Gene Expression at the Single Cell Level in Human Colon and Mammary Carcinomas

P. Hand, A. Thor, J. Schlom, 1985 .

Interspecies radioimmunoassay for the major internal protein of mammary tumor viruses.

P. Hand, J. Schlom, R. Callahan, 1980, Virology.

16 – Colon Carcinoma Cell Population as Defined by Monoclonal Antibodies

S. Pestka, P. Hand, A. Thor, 1990 .

Detection of novel murine mammary tumor viruses by interspecies immunoassays.

P. Hand, J. Schlom, R. Callahan, 1980, Journal of the National Cancer Institute.

Characterization of a new virus from Mus cervicolor immunologically related to the mouse mammary tumor virus.

P. Hand, J. Schlom, R. Callahan, 1978, Journal of the National Cancer Institute.

Mutant ras epitopes as targets for cancer vaccines.

P. Hand, J. Schlom, S. Abrams, 1996, Seminars in oncology.

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines

S. Steinberg, A. Chen, J. Marshall, 2000, Cancer Immunology, Immunotherapy.

Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.

S. Pestka, P. Fisher, F. Guadagni, 1990, Cancer treatment and research.

Tumor Associated Antigens and Oncogene Products Defined by Monoclonal Antibodies

P. Hand, A. Thor, J. Schlom, 1987 .

Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.

P. Hand, A. Thor, J. Schlom, 1987, Journal of the National Cancer Institute.

Reactivities of an anti-CEA peptide monoclonal antibody

M. Kuroki, P. Hand, J. Schlom, 1992, The International journal of biological markers.

Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen.

P. Hand, J. Schlom, M. Nuti, 1983, Cancer Investigation.

Biologic properties of a Ch2 domain‐deleted recombinant immunoglobulin

P. Hand, J. Schlom, B. Calvo, 1993, International journal of cancer.

Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.

P. Hand, J. Schlom, D. Salomon, 1985, Cancer research.

Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.

P. Hand, J. Schlom, J. Carrasquillo, 1995, Cancer research.